Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety, Dosimetry and Efficacy of 177Lu-INN805 Injection in Patients With Malignant Solid Tumors

NCT07459283 is registered in ClinicalTrials.gov with FindCure Biosciences (ZhongShan) Co., Ltd. as lead sponsor.

NCT NCT07459283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07459283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety, Dosimetry and Efficacy of 177Lu-INN805 Injection in Patients With Malignant Solid Tumors
Lead sponsor
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
April 20, 2026
Completion date
March 31, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, head & neck cancer, lung cancer - non small cell squamous, maligant solid tumor, sarcoma, thyroid cancer